Ignite Creation Date:
2025-12-24 @ 1:42 PM
Ignite Modification Date:
2026-05-02 @ 2:45 AM
Study NCT ID:
NCT02836795
Status:
COMPLETED
Last Update Posted:
2025-06-08
First Post:
2016-07-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Tolerability of Recombinant Humanized Anti-PD-1 Monoclonal Antibody Toripalimab for Patients With Advanced Solid Tumors
Sponsor:
Shanghai Junshi Bioscience Co., Ltd.
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Junshi-JS001-BJZL-I
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None